Fortune 500 Multinational Healthcare Corporation’s Adds ScoutCam to its Approved Supplier List

OMER, Israel, September 8, 2020 - Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that it was informed by ScoutCam, Inc. (OTC: SCTC), Medigus’ subsidiary and a
leading developer and manufacturer of customized visual solutions and supplementary technologies, that ScoutCam has been officially included on a
Fortune 500 multinational healthcare corporation’s Approved Supplier List (ASL). The qualification will allow ScoutCam to develop, manufacture and
supply a complete visualization solution for the global company’s minimally invasive surgical product, which incorporates ScoutCam’s single-use
miniature video cameras.

“We are extremely excited not only for the recognition of our superior technology, but for the opportunity to become a long-term supplier of innovative visualization tools that has the potential to transform minimally invasive surgeries, and all under the strictest quality standards of this global leader,” said Yaron Silberman, Chief Executive Officer of ScoutCam.
The two companies initially began collaborating back in 2018 and in mid-2019, a formal audit at ScoutCam’s facilities was completed. This past May, the
global standard Supplier Quality Agreement (SQA) of the customer was signed. ScoutCam provided a final quote to the healthcare corporation in May as
well, which included development fees of $2.4 million to be paid per milestones in 2020-2021 and prices per ordered quantities for the supply of the final
deliverables, ranging in hundreds of USD per unit. ScoutCam’s inclusion on the ASL encompasses all of its business units, in addition to the one in which
ScoutCam is currently engaged.

“Now that we have officially been added to the Approved Supplier List, ScoutCam is expected to sell tens of thousands of single-use cameras annually in the next few years, which gives us the opportunity to transform minimally invasive surgeries as we know them,” Silberman continued. “Overall, we are extremely happy with the recognition, and we are proud that such partnership presents a parallel benefit to both patients and doctors alike.”